News & Media

IBA News & Media Room

Spacer

Filter by media type:

Filter by media category:

Filter by date created:

Spacer

Press release

23.12.2021

Proton therapy

IBA and Proton International sign contract for Proteus®ONE Proton Therapy solution in Arkansas, US

EN

FR

>

Press release

21.12.2021

Proton therapy

IBA and New Mexico Cancer Center sign contract to install a Proteus®ONE proton therapy solution in Albuquerque, USA

EN

FR

>

Press release

20.12.2021

Industrial Solutions

IBA launches INDux, a new training center designed to optimize customer performance and increase the uptime of their solution

EN

>

Press release

19.11.2021

Proton therapy

IBA and the Oncology Reference Center of Aviano, Italy, sign contract to install a Proteus®ONE Proton Therapy system

EN

FR

>

Press release

28.10.2021

Industrial Solutions

IBA and TRAD Tests & Radiations announce collaboration to develop next generation radiation processing application

EN

FR

>

Press release

26.10.2021

Proton therapy

IBA and RaySearch expand their partnership in proton therapy

EN

>

Press release

25.10.2021

Proton therapy

IBA and the University of Pennsylvania partner to advance research of ConformalFLASH® therapy

EN

>

Press release

24.10.2021

Proton therapy

Proton Therapy contract finalized with Advocate Radiation Oncology Affiliate in Florida

EN

FR

>

Press release

20.10.2021

Proton therapy

IBA launches Campus: the world’s first online proton therapy platform

EN

FR

>

Press release

27.08.2021

Proton therapy

IBA continues to shape the future of proton therapy at ESTRO 2021 Annual Congress

EN

>

Press release

24.08.2021

Proton therapy

IBA and partners launch significant proton therapy clinical trial

EN

FR

>

Press release

12.08.2021

Proton therapy

IBA Receives Down Payment for a Proteus®PLUS System in China

EN

FR

CN

>

1 of 2
next ›

Cookies policy

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et des offres adaptés à vos centres d’intérêts.